Association Between SARS-CoV-2 RNAemia and Postacute Sequelae of COVID-19

Mostrar otras versiones (1)

Determinants of Post-Acute Sequelae of COVID-19 are not known. Here we show that 83.3% of patients with viral RNA in blood (RNAemia) at presentation were symptomatic in the post-acute phase. RNAemia at presentation successfully predicted PASC, independent of patient demographics, worst disease sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Ram-Mohan, Nikhil, Kim, David, Rogers, Angela J, Blish, Catherine A, Nadeau, Kari C, Blomkalns, Andra L, Yang, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802799/
https://www.ncbi.nlm.nih.gov/pubmed/35111870
http://dx.doi.org/10.1093/ofid/ofab646
Descripción
Sumario:Determinants of Post-Acute Sequelae of COVID-19 are not known. Here we show that 83.3% of patients with viral RNA in blood (RNAemia) at presentation were symptomatic in the post-acute phase. RNAemia at presentation successfully predicted PASC, independent of patient demographics, worst disease severity, and length of symptoms.

Ejemplares similares